Merint Molecular Imaging Private Limited, a active private limited company, was established on 02 August 2006 in Mumbai, Maharashtra, India. Engaging in real estate leasing within the real estate sector, it holds CIN: U74999MH2006PTC163467. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.10 Cr and a paid-up capital of ₹2.03 Cr.
It upholds a compliant status. Its leadership includes Sukoon Akshay Sethi (Director), Fazal Mahemood Kassam Ali Manekia (Director). Past directors included Sukoon Akshay Sethi, Salma Fazal Manekia, Rakeshkumar Jatashankar Pathak. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Diagod,Offcarterroad,Sherlyrajanroad,Bandra(West),, Mumbai, Maharashtra, 400050.
U74999MH2006PTC163467
163467
02 August 2006
₹2.10 Cr
₹2.03 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Merint Molecular Imaging Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sukoon Akshay Sethi | Director | 10 Sep 2012 | Current |
| Fazal Mahemood Kassam Ali Manekia | Director | 02 Aug 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2012 | Past |
| Pramod Abcsdd | Director | 04 Sep 2016 | Past |
| Pramod Abcsdd | Director | 19 Sep 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Merint Molecular Imaging Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 123.93% increase in profit. The company's net worth moved up by a moderate rise of 0.38%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Merint Molecular Imaging had a promoter holding of 72.37% and a public holding of 27.63%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Merint Molecular Imaging, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Merint Molecular Imaging, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Merint Molecular Imaging's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Merint Molecular Imaging Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Merint Molecular Imaging Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The activity Sukoon Akshay Sethi was appointed as a Director was appointed as a Director on 10 Sep 2012 & has been associated with this company since 13 years 2 months . was completed.
The activity Fazal Mahemood Kassam Ali Manekia was appointed as a Director was appointed as a Director on 02 Aug 2006 & has been associated with this company since 19 years 3 months . was completed.
The activity Merint Molecular Imaging Private Limited was registered on 02 Aug 2006 with Roc Mumbai & aged 19 years 3 months as per MCA records. was completed.
The CIN of Merint Molecular Imaging Private Limited is U74999MH2006PTC163467.
Merint Molecular Imaging Private Limited is headquartered at Diagod,Offcarterroad,Sherlyrajanroad,Bandra(West),, Mumbai, Maharashtra, 400050.
Merint Molecular Imaging Private Limited was incorporated on 02 August 2006.
The current directors of Merint Molecular Imaging Private Limited are
The primary industry of Merint Molecular Imaging Private Limited is Real Estate.
Merint Molecular Imaging Private Limited is unlisted.
The authorized capital of Merint Molecular Imaging Private Limited is ₹2.10 Cr, and the paid-up capital is ₹2.03 Cr.
The compliance status of Merint Molecular Imaging Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX